Online citations, reference lists, and bibliographies.
← Back to Search

Clinical Evaluation Of Omega-3 Fatty Acids In Psoriasis

M. Adil, P. K. Singh, K. Maheshwari
Published 2017 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Introduction: Omega-3 fatty acids are largely derived from fish oils and are known to decrease inflammation. There have been a few small studies showing the beneficial effect of omega-3 fatty acids in psoriasis. Objective: To evaluate the efficacy of omega-3 fatty acids in conjunction with emollients in patients with mild to moderate chronic plaque psoriasis. Materials and methods: A total of 200 clinically diagnosed cases of chronic plaque psoriasis with less than 10% of body surface area involvement were recruited and divided into group A and group B. Group A was given 1,800 mg daily of omega-3 fatty acids in three divided oral doses and topical paraffin over the lesions. Group B was prescribed only topical paraffin. At the end of 12 weeks, treatment response was assessed by means of Psoriasis Area Severity Index (PASI), and by its components including area involved, erythema, induration and desquamation scores. Results: The mean PASI score changed from 7.44 to 3.96 in group A, and from 7.24 to 5.19 in group B. There was a statistically significant difference in PASI, erythema, induration, desquamation scores and area involved between the two groups after 12 weeks. Forty four (46.3%) patients in group A and 13 (13.9%) patients in group B achieved a 50% or more reduction in PASI scores. Conclusions: Omega-3 fatty acids in conjunction with topical emollients appear to reduce the severity of psoriasis with no major side effects. The combination can be a useful adjunct to other psoriasis treatments.
This paper references
10.1016/j.biochi.2009.01.008
Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale.
P. Calder (2009)
10.1111/j.1365-2230.1992.tb00194.x
Topical fish oil in psoriasis—a controlled and blind study
S. Escobar (1992)
10.1016/j.clnu.2013.09.010
Energy-restricted, n-3 polyunsaturated fatty acids-rich diet improves the clinical response to immuno-modulating drugs in obese patients with plaque-type psoriasis: a randomized control clinical trial.
B. Guida (2014)
Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial.
P. Mayser (1998)
0 Omega-3 fatty acid : Living longer happier from complexities
Girish P. Laddha (2012)
10.1016/J.JAAD.2003.09.014
A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis.
Christopher S Carlin (2004)
10.1056/NEJM199306243282504
Effect of dietary supplementation with very-long-chain n-3 fatty acids in patients with psoriasis.
E. Søyland (1993)
10.4103/0378-6323.72443
Psoriasis in India: prevalence and pattern.
S. Dogra (2010)
10.1684/ejd.2014.2511
The relationship between quality of life and the severity of psoriasis in Turkey
Hülya Çakmur (2015)
10.1177/030006059001800109
Effects of Dietary Supplementation with Polyunsaturated Ethyl Ester Lipids (Angiosan®) in Patients with Psoriasis and Psoriatic Arthritis
A. Lassus (1990)
10.1111/j.1365-2133.1989.tb01378.x
Double‐blind, placebo‐controlled study to evaluate the efficacy of fish oil and low‐dose UVB in the treatment of psoriasis
A. Gupta (1989)
10.1001/archdermatol.2010.370
Prevalence of the metabolic syndrome in psoriasis: results from the National Health and Nutrition Examination Survey, 2003-2006.
T. Love (2011)
10.1002/9780470750520
Rook's Textbook of Dermatology
A. Rook (2004)
10.1155/MI.2005.273
Serum Levels of TNF-α, IFN-γ, IL-6, IL-8, IL-12, IL-17, and IL-18 in Patients With Active Psoriasis and Correlation With Disease Severity
O. Arican (2005)
10.1016/S0140-6736(88)91181-6
A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED TRIAL OF FISH OIL IN PSORIASIS
S. B. Bittiner (1988)
10.1684/EJD.2007.0201
Is there a role for topically delivered eicosapentaenoic acid in the treatment of psoriasis?
Modh Hanif Zulfakar (2007)
10.2147/CCID.S17220
Study on the use of omega-3 fatty acids as a therapeutic supplement in treatment of psoriasis
G. M. Balbás (2011)
A low-fat diet supplemented with dietary fish oil (Max-EPA) results in improvement of psoriasis and in formation of leukotriene B5.
K. Kragballe (1989)
10.1111/j.1365-2133.1993.tb03338.x
Highly purified omega‐3‐polyunsaturated fatty acids for topical treatment of psoriasis. Results of a double‐blind, placebo‐controlled multicentre study
H.‐H. HENNEICKE‐VON ZEPELIN (1993)
10.1038/jid.2009.399
Circulating Th17, Th22, and Th1 cells are increased in psoriasis.
S. Kagami (2010)
10.1016/j.jaad.2008.09.022
The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: results from NHANES 2003-2004.
S. Kurd (2009)
10.1111/j.1365-4362.1990.tb03477.x
The Role of Fish Oil in Psoriasis
A. Gupta (1990)
An overview of psoriasis and the role of emollient therapy.
Julie Van Onselen (2013)
10.1007/978-1-62703-167-7_7
Omega 3 Fatty Acids in Psoriasis
A. Upaganlawar (2013)
10.1007/978-3-319-40458-5_38
Beneficial Effect of Long-Chain Omega-3 Fatty Acids in Psoriasis
Mahfoozur Rahman (2016)
10.1111/1346-8138.12569
HLA‐C*12:02 is a susceptibility factor in late‐onset type of psoriasis in Japanese
T. Mabuchi (2014)
10.1007/BF00184491
A double-blind, randomized, placebo-controlled trial of n-3 fatty acid based lipid infusion in acute, extended guttate psoriasis
F. Grimminger (2004)
10.7241/ourd.20131.03
CLINICAL EVALUATION OF DIFFERENT THERAPEUTIC MODALITIES IN PSORIASIS BY PASI SCORE
N. Puri (2012)
10.1079/BJN2001459
n-3 fatty acids in psoriasis.
P. Mayser (2002)
Psoriasis--pathophysiology, conventional, and alternative approaches to treatment.
M. Traub (2007)
10.1111/1756-185X.13051
Effect of omega‐3 fatty acids on disease severity in patients with psoriasis: A systematic review
S. Upala (2017)
10.1186/s41110-016-0029-3
n-3 polyunsaturated fatty acids supplementation in psoriasis: a review
Naiara Lourenço Mari (2017)
10.1111/j.1468-3083.2009.03562.x
What are the best outcome measures for assessing plaque psoriasis severity? A systematic review of the literature
E. Puzenat (2010)
10.1001/archfaci.10.4.286
Fitzpatrick's Dermatology in General Medicine
Tobias Pincock (2003)



This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar